Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05972928
PHASE2/PHASE3
Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients
Sponsor: Beni-Suef University
View on ClinicalTrials.gov
Summary
The Study aims to determine the proposed positive influence of Sitagliptin in manipulating hormonal , metabolic and inflammatory parameters in the treatment of Polycystic ovary syndrome and subsequent infertility
Official title: Effect of Sitagliptin on Clinical, Metabolic and Hormonal Parameters in Polycystic Ovarian Syndrome Patients
Key Details
Gender
FEMALE
Age Range
20 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2024-08-07
Completion Date
2025-07-31
Last Updated
2026-09-01
Healthy Volunteers
No
Conditions
Interventions
DRUG
Sitagliptin 100mg
Sitagliptin at a dose of 100 mg every 24 hours for 3 months
Locations (1)
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt